𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cholinergic Treatment of Alzheimer’s Disease and Its Influence on Health and the Quality of Life of Carers

✍ Scribed by I. V. Kolykhalov; G. A. Rassadina; S. I. Gavrilova; N. P. Gerasimov


Publisher
Springer US
Year
2011
Tongue
English
Weight
131 KB
Volume
41
Category
Article
ISSN
0097-0549

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Assessing the relationship between healt
✍ Edward Alan Miller; Lon S. Schneider; Robert A. Rosenheck 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## Abstract ## Objectives To examine the relationship between use of multiple health services and health utilities, quality of life and other factors in Alzheimer's disease (AD). ## Design Data were obtained via caregiver proxy at baseline and 3‐ 6‐ and 9‐months post‐random assignment among 421

Coping processes and health-related qual
✍ R. S. Bucks; K. E. Cruise; T. C. Skinner; A. M. Loftus; R. A. Barker; M. G. Thom 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

## Abstract ## Objective This study investigated the predictive value of various coping processes for the psychological and disease specific aspects of health‐related quality of life (HRQoL) in Parkinson's disease (PD). ## Method Cross‐sectional study of 85 participants with PD using the Ways of

Predictors and course of health-related
✍ Elin Bjelland Forsaa; Jan Petter Larsen; Tore Wentzel-Larsen; Karen Herlofson; G 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

## Abstract We investigated how health related quality of life (HRQL) changes over time in a population‐based cohort of patients with Parkinson's disease (PD), and which factors predict a lower level of HRQL in these patients. Of 227 patients with PD assessed at baseline and followed prospectively,

Health-related quality of life in chroni
✍ John E. Ware Jr; Martha S. Bayliss; Michael Mannocchia; Gary L. Davis 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

Hepatitis C infects nearly 4 million Americans. Most have chronic hepatitis C (CHC), which progresses to cirrhosis in about 20% of patients. Interferon treatment leads to transient responses in about 40% of patients and apparent eradication of infection in 7% to 40% of patients. In this report, we d